During the past decade, University Neurology, Inc. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Neurology, Inc." #1 sponsor was "Impax Laboratories, LLC" with 4 trials, followed by "Alector Inc." with 1 trials sponsored, "Amicus Therapeutics" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

According to Clinical.Site data, the most researched conditions in "University Neurology, Inc." are "Parkinson's Disease" (2 trials), "Alzheimer's Disease" (1 trials), "Cervical Dystonia" (1 trials), "Epilepsy" (1 trials) and "Epilepsy, Generalized" (1 trials). Many other conditions were trialed in "University Neurology, Inc." in a lesser frequency.

Most popular intervention types in "University Neurology, Inc." are "Drug" (13 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "AL001" (1 trials), "AT2221" (1 trials), "ATB200" (1 trials) and "CLE" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Neurology, Inc." are 14 trials for "All" genders.

Currently, there are NaN active trials in "University Neurology, Inc.". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in University Neurology, Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University Neurology, Inc., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".